Literature DB >> 22693250

VEGF exerts an angiogenesis-independent function in cancer cells to promote their malignant progression.

Ying Cao1, Guangqi E, Enfeng Wang, Krishnendu Pal, Shamit K Dutta, Dafna Bar-Sagi, Debabrata Mukhopadhyay.   

Abstract

VEGF/vascular permeability factor (VEGF/VPF or VEGF-A) is a pivotal driver of cancer angiogenesis that is a central therapeutic target in the treatment of malignancy. However, little work has been devoted to investigating functions of VEGF that are independent of its proangiogenic activity. Here, we report that VEGF produced by tumor cells acts in an autocrine manner to promote cell growth through interaction with the VEGF receptor neuropilin-1 (NRP-1). Reducing VEGF expression by tumor cells induced a differentiated phenotype in vitro and inhibited tumor forming capacity in vivo, independent of effects on angiogenesis. Autocrine activation of tumor cell growth was dependent on signaling through NRP-1, and Ras was determined to be a critical effector signaling molecule downstream of NRP-1. Our findings define a novel function for VEGF in dedifferentiation of tumor cells expanding its role in cancer beyond its known proangiogenic function. ©2012 AACR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22693250      PMCID: PMC3427728          DOI: 10.1158/0008-5472.CAN-11-4058

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

Review 1.  VEGF: an update on biological and therapeutic aspects.

Authors:  N Ferrara
Journal:  Curr Opin Biotechnol       Date:  2000-12       Impact factor: 9.740

2.  Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells.

Authors:  R E Bachelder; A Crago; J Chung; M A Wendt; L M Shaw; G Robinson; A M Mercurio
Journal:  Cancer Res       Date:  2001-08-01       Impact factor: 12.701

3.  Acceleration of clear cell renal cell carcinoma growth in mice following bevacizumab/Avastin treatment: the role of CXCL cytokines.

Authors:  R Grepin; M Guyot; M Jacquin; J Durivault; E Chamorey; A Sudaka; C Serdjebi; B Lacarelle; J-Y Scoazec; S Negrier; H Simonnet; G Pages
Journal:  Oncogene       Date:  2011-09-12       Impact factor: 9.867

4.  Cloning and characterization of neuropilin-1-interacting protein: a PSD-95/Dlg/ZO-1 domain-containing protein that interacts with the cytoplasmic domain of neuropilin-1.

Authors:  H Cai; R R Reed
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

5.  Neuropilin-1-mediated vascular permeability factor/vascular endothelial growth factor-dependent endothelial cell migration.

Authors:  Ling Wang; Huiyan Zeng; Ping Wang; Shay Soker; Debabrata Mukhopadhyay
Journal:  J Biol Chem       Date:  2003-09-26       Impact factor: 5.157

6.  Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase.

Authors:  D D Schlaepfer; S K Hanks; T Hunter; P van der Geer
Journal:  Nature       Date:  1994 Dec 22-29       Impact factor: 49.962

7.  Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain.

Authors:  S Soker; H Fidder; G Neufeld; M Klagsbrun
Journal:  J Biol Chem       Date:  1996-03-08       Impact factor: 5.157

8.  Neuropilin-1 extracellular domains mediate semaphorin D/III-induced growth cone collapse.

Authors:  F Nakamura; M Tanaka; T Takahashi; R G Kalb; S M Strittmatter
Journal:  Neuron       Date:  1998-11       Impact factor: 17.173

9.  Isolation of a tumor factor responsible for angiogenesis.

Authors:  J Folkman; E Merler; C Abernathy; G Williams
Journal:  J Exp Med       Date:  1971-02-01       Impact factor: 14.307

10.  Neuropilin-1 modulates p53/caspases axis to promote endothelial cell survival.

Authors:  Ling Wang; Shamit K Dutta; Tatsuyoshi Kojima; Xiaolei Xu; Roya Khosravi-Far; Stephen C Ekker; Debabrata Mukhopadhyay
Journal:  PLoS One       Date:  2007-11-14       Impact factor: 3.240

View more
  61 in total

Review 1.  Genetic status of KRAS influences Transforming Growth Factor-beta (TGF-β) signaling: An insight into Neuropilin-1 (NRP1) mediated tumorigenesis.

Authors:  Sneha Vivekanandhan; Debabrata Mukhopadhyay
Journal:  Semin Cancer Biol       Date:  2018-02-02       Impact factor: 15.707

2.  Prognostic value and in vitro biological relevance of Neuropilin 1 and Neuropilin 2 in osteosarcoma.

Authors:  Aleksandar Boro; Matthias Je Arlt; Harald Lengnick; Bernhard Robl; Maren Husmann; Josefine Bertz; Walter Born; Bruno Fuchs
Journal:  Am J Transl Res       Date:  2015-03-15       Impact factor: 4.060

3.  Neuropilin-1 is overexpressed in osteosarcoma and contributes to tumor progression and poor prognosis.

Authors:  H Zhu; H Cai; M Tang; J Tang
Journal:  Clin Transl Oncol       Date:  2013-12-12       Impact factor: 3.405

4.  RUNX1 Regulates Migration, Invasion, and Angiogenesis via p38 MAPK Pathway in Human Glioblastoma.

Authors:  Kant Sangpairoj; Pornpun Vivithanaporn; Somjai Apisawetakan; Sukumal Chongthammakun; Prasert Sobhon; Kulathida Chaithirayanon
Journal:  Cell Mol Neurobiol       Date:  2016-12-24       Impact factor: 5.046

5.  Emodin inhibits HMGB1-induced tumor angiogenesis in human osteosarcoma by regulating SIRT1.

Authors:  Wei Qu; Yufei Wang; Qining Wu; Jijun Liu; Dingjun Hao
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 6.  Canonical and noncanonical vascular endothelial growth factor pathways: new developments in biology and signal transduction.

Authors:  Courtney K Domigan; Safiyyah Ziyad; M Luisa Iruela-Arispe
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-10-02       Impact factor: 8.311

7.  NRP-1 interacts with GIPC1 and α6/β4-integrins to increase YAP1/∆Np63α-dependent epidermal cancer stem cell survival.

Authors:  Daniel Grun; Gautam Adhikary; Richard L Eckert
Journal:  Oncogene       Date:  2018-05-14       Impact factor: 9.867

8.  NRP-1 interacts with GIPC1 and SYX to activate p38 MAPK signaling and cancer stem cell survival.

Authors:  Daniel Grun; Gautam Adhikary; Richard L Eckert
Journal:  Mol Carcinog       Date:  2018-12-21       Impact factor: 4.784

9.  Effect of tumor microenvironment on tumor VEGF during anti-VEGF treatment: systems biology predictions.

Authors:  Stacey D Finley; Aleksander S Popel
Journal:  J Natl Cancer Inst       Date:  2013-05-13       Impact factor: 13.506

10.  Promoter CpG island methylation of genes in key cancer pathways associates with clinical outcome in high-grade serous ovarian cancer.

Authors:  Wei Dai; Constanze Zeller; Nahal Masrour; Nadeem Siddiqui; James Paul; Robert Brown
Journal:  Clin Cancer Res       Date:  2013-08-21       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.